Member Info for marik

The Telegram group is the best place for this kind of discussion. The debates are more about the facts and less about what the green boxes want to do. It's like when the bully was excluded from school.

I'm finding general attendance is up and with the big releases now taking place it bodes well for cineworld.

Its been rising exceptionally well for a while.

Its a great long term investment and could be set up for a nice short one as well.

This is shaping up nicely for take off in the near future.

You could be right QS. I was thinking similar to the lines of end of month.

@sgf ignore the comments by Glen, it's another nd account or one of the crew.

The shallow targets and seismic survey before year end is ambitious, but I'm liking the exceptional energy shown by the CEO. DM is a great leader and I think he might bring it home by end November.

I agree, if we get a shallow hit, then this would be good all round. However, I'm very optimistic about David Minchin at the helm. He reminds me a lot of Alessandro Zamboni. I think he is about to hit it out of the park.

Recent data collection from the Tai-1 and Tai-2 revealed a marked difference in the amount of Helium detected. As Tai-1 and Tai-2 are in close proximity, the data from both can be analysed to optimise geophysical techniques to quickly and cheaply progress on both 'Shallow' and 'Deep' targets. This marks the start of with the aim of commercial discovery.

I've listened to the directors interviews again and I can see that DM is on a mission to progress things quite fast. As the company is well financed, the data from Tai-1 and Tai-2 allow for cost-effective exploration. Looking forward to drilling very soon.

I think this is a solid buy and continue to add as we see a rise in share price in anticipation.

GLA

SYME looks like a genuinely good company with a lot of potential. I can't figure who is genuine bar a few names, but those that do contribute regularly are quite good.

Well said Captain.

A fantastic thesis based on solid research and analysis.

I've seen this posted before, but it's relating to antibody as opposed to antigen. This is more related to ODX as opposed to Avacta and it's very small funding at
£46,962.

Secondly, I'm looking forward to AVA6000 trial (or rather as long as it continues with no news), and the European and Worldwide agreements for Affidx, and Home Use.

Plenty of action at Avacta over the next 3-4 weeks.

https://bidstats.uk/tenders/2021/W35/758120876

I'm thanking Dr Al Smith for being astute enough not to burn the Government bridge but at the same time forging ahead with European, Worldwide distribution along with focusing on bigger contracts.

Pulse of Fintech H1'21

I'm not a fan of KPMG reports, but this presentation is very good:

https://assets.kpmg/content/dam/kpmg/xx/pdf/2021/08/pulse-of-fintech-h1.pdf

Roundhowe, I agree that we could well be in week 9, however I've kept it conservative as I know that some will object to the optimism and also its help manage expectations.

(The added benefit being that if you are right on the 9 weeks, this will creep up on the nay sayers very quickly.)

Speaking of Mergers and Acquisitions, ARC Group have been voted the best Global mid-market investment bank in the International Investor Award 2020. What is fascinating is their Mergers & Acquisitions section is also fantastic.

https://www.arccap.us/services/mergers-acquisitions/

Signs of bigger things to come!

A quick summary of 2020, illustrates that despite the pandemic, this space has kept going strong.

https://thefintechtimes.com/a-year-in-fintech-2021-mergers-and-acquisitions/

Some great acquisitions in the fintech space for June 2021. It goes to show that there is a real hunger for fintech at the moment and a lot of growth for the future.

https://ibsintelligence.com/ibsi-news/fintech-mergers-acquisitions-america-june-2021/

I'll add more to this in the near future.

With us fast approaching week 6, the dose will be in excess of 400mg/m2. Before the end of this month, the upward pressure on the share price will be phenomenal. That said, the Jupiter short will likely reduce as the profit margins are reduced and Jupiter goes into the red (by my calculations, that is somewhere in the 140s).

When the resistance around 143/144, breaks, there won't be much choice left but for the shorts to close and a rapid rise to 160 and 180 on the horizon.

This month looks very exciting.

GLA LTH

"Very sick people taking part in AVA6000 trial so yes fingers crossed for a "positive outcome " for all concerned ."

Great point gmcc, this will transform the way that chemotherapy and cancer patients are treated. The impact on patients is priceless.

"A hugely exciting four months ahead. If the AVA6000 PK data (due within next four months - likely less than three months) are positive, Avacta will have a very real opportunity of catapulting to multi-billion pound mkt cap status in relatively short order."

To add, the multi-billion market cap may happen through one of the other feathers in Avacta's cap. Looking forward to this month.